Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Oklahoma City, Oklahoma 73104


Purpose:

Investigate the role of tegaserod in modulating gastric sensitivity to mechanical distention of the stomach


Criteria:

Inclusion Criteria: - Male or female subjects at least 18 years of age. - Subjects willing to undergo multiple nasogastric intubations. - Patients with functional heartburn will need to meet ROME II criteria. - Patients with symptoms consistent with dyspepsia (epigastric pain/discomfort characterized by bloating, postprandial fullness and early satiety) Exclusion Criteria: - Subjects with clinically significant diarrhea or a diagnosis of diarrhea-predominant IBS. - Subjects with a diagnosis of IBD, Barrett's esophagus, esophageal stricture or ring, or previous or current history of ulcer disease. - Subjects with Diffuse Esophageal Spasm or Achalasia. Other protocol-defined inclusion/exclusion criteria may apply.


NCT ID:

NCT00171457


Primary Contact:

Study Director
Novartis
Novartis


Backup Contact:

N/A


Location Contact:

Oklahoma City, Oklahoma 73104
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.